NO20073353L - Produkt som har prostaglandin som har fluoratom i molekyl - Google Patents

Produkt som har prostaglandin som har fluoratom i molekyl

Info

Publication number
NO20073353L
NO20073353L NO20073353A NO20073353A NO20073353L NO 20073353 L NO20073353 L NO 20073353L NO 20073353 A NO20073353 A NO 20073353A NO 20073353 A NO20073353 A NO 20073353A NO 20073353 L NO20073353 L NO 20073353L
Authority
NO
Norway
Prior art keywords
prostaglandin
molecule
fluorine atom
aqueous liquid
product
Prior art date
Application number
NO20073353A
Other languages
English (en)
Other versions
NO341174B1 (no
Inventor
Akio Kimura
Hiroyuki Asada
Takehiro Kado
Tomoyuki Okamoto
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of NO20073353L publication Critical patent/NO20073353L/no
Publication of NO341174B1 publication Critical patent/NO341174B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Packages (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

Et formål for den foreliggende oppfinnelse er å tilveiebringe et prostaglandinholdig produkt hvori når et vandig flytende preparat innholdende et prostaglandinderivat med i det minste et fluoratom i sitt molekyl som en aktiv bestanddel lagres i en harpiksbeholder som underkastes en steriliseringsbehandling, kan en minsking i innholdet av prostaglandinderivatet i det vandige flytende preparat inhiberes. Det vandige flytende preparat inneholdende prostaglandinderivatet med i det minste et fluoratom i sitt molekyl som en aktiv bestanddel lagres i harpiksbeholderen som underkastes en steriliseringsbehandling med etylenoksidgass. Ved å gjøre dette kan en minsking i innholdet av prostaglandinderivatet i det vandige flytende preparat inhiberes.
NO20073353A 2004-12-09 2007-06-29 Fluorholding prostaglandinprodukt og fremgangsmåte for fremstilling NO341174B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004356969 2004-12-09
PCT/JP2005/022618 WO2006062184A1 (ja) 2004-12-09 2005-12-09 分子内にフッ素原子を有するプロスタグランジン含有製品

Publications (2)

Publication Number Publication Date
NO20073353L true NO20073353L (no) 2007-08-27
NO341174B1 NO341174B1 (no) 2017-09-04

Family

ID=36578004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073353A NO341174B1 (no) 2004-12-09 2007-06-29 Fluorholding prostaglandinprodukt og fremgangsmåte for fremstilling

Country Status (10)

Country Link
US (1) US20080139648A1 (no)
EP (1) EP1825855B1 (no)
JP (2) JP2006187602A (no)
KR (1) KR101305649B1 (no)
CN (2) CN102526064A (no)
CA (1) CA2590277C (no)
ES (1) ES2588581T3 (no)
NO (1) NO341174B1 (no)
RU (1) RU2429849C2 (no)
WO (1) WO2006062184A1 (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4753178B2 (ja) * 2004-12-24 2011-08-24 参天製薬株式会社 プロスタグランジンＦ２α誘導体含有製品
JP2008247828A (ja) * 2007-03-30 2008-10-16 Wakamoto Pharmaceut Co Ltd ラタノプロストを含有する水性医薬組成物。
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
WO2010027040A1 (ja) * 2008-09-04 2010-03-11 参天製薬株式会社 １５，１５－ジフルオロプロスタグランジンＦ2α誘導体を有効成分として含有する毛髪成長促進剤
RU2482851C2 (ru) * 2009-02-20 2013-05-27 Микро Лабс Лимитед Хранение стабильного продукта простагландина
EP2269575A1 (en) 2009-06-30 2011-01-05 Santen Pharmaceutical Co., Ltd Method for improving bioavailability of latanoprost
EP2979695B1 (en) 2013-03-29 2018-08-01 AskAt Inc. Therapeutic agent for ocular disease
JP7037349B2 (ja) * 2017-06-23 2022-03-16 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
WO2018235935A1 (ja) * 2017-06-23 2018-12-27 参天製薬株式会社 水溶性粘稠化剤を含有する医薬組成物
KR20200035047A (ko) 2017-08-03 2020-04-01 산텐 세이야꾸 가부시키가이샤 클로르헥시딘을 함유하는 의약 조성물
JP6798054B1 (ja) * 2020-02-19 2020-12-09 千寿製薬株式会社 医薬製品
JP6855632B1 (ja) * 2020-02-19 2021-04-07 千寿製薬株式会社 医薬製品
JPWO2022014707A1 (no) 2020-07-16 2022-01-20
TW202448475A (zh) * 2023-03-31 2024-12-16 日商樂敦製藥股份有限公司 眼科組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310543A (en) * 1980-10-09 1982-01-12 Hoffmann-La Roche Inc. Prostaglandin compositions
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
US5565492A (en) * 1988-07-18 1996-10-15 Alcon Laboratories, Inc. Prostaglandin combinations in glaucoma therapy
US5486540A (en) * 1993-10-28 1996-01-23 Allergan, Inc. Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents
JP3480549B2 (ja) * 1996-12-26 2003-12-22 参天製薬株式会社 ジフルオロプロスタグランジン誘導体およびその用途
US6235781B1 (en) * 1998-07-14 2001-05-22 Alcon Laboratories, Inc. Prostaglandin product
BR9906597A (pt) * 1998-07-14 2000-07-18 Alcon Lab Inc Produto de prostaglandina
US6440364B1 (en) * 1999-02-16 2002-08-27 Ethicon, Inc. Method of degassing absorbable suture products
EP1352837B1 (en) * 1999-05-28 2006-02-22 Novartis AG Process for manufacturing a sterilized squeezable package for a pharmaceutical product
DK1321144T3 (da) * 2000-09-13 2011-03-07 Santen Pharmaceutical Co Ltd Øjendråber
WO2002022106A2 (en) * 2000-09-14 2002-03-21 Novartis Ag Stable ophthalmic preparation
TW586946B (en) * 2000-12-22 2004-05-11 Novartis Ag Process to improve stability
JP4092507B2 (ja) * 2003-07-31 2008-05-28 参天製薬株式会社 プロスタグランジン含有製品
ATE450264T1 (de) * 2003-07-31 2009-12-15 Santen Pharmaceutical Co Ltd Prostaglandin enthaltendes produkt
US20050049311A1 (en) * 2003-09-03 2005-03-03 Pharmacia & Upjohn Company Medicinal products comprising prostaglandin compositions and methods of packaging such compositions

Also Published As

Publication number Publication date
CN102526064A (zh) 2012-07-04
KR101305649B1 (ko) 2013-09-09
JP5323040B2 (ja) 2013-10-23
RU2429849C2 (ru) 2011-09-27
RU2007125699A (ru) 2009-01-20
WO2006062184A1 (ja) 2006-06-15
NO341174B1 (no) 2017-09-04
JP2006187602A (ja) 2006-07-20
ES2588581T3 (es) 2016-11-03
JP2011063625A (ja) 2011-03-31
CN101072568A (zh) 2007-11-14
EP1825855A1 (en) 2007-08-29
EP1825855B1 (en) 2016-08-17
EP1825855A4 (en) 2010-09-08
CA2590277A1 (en) 2006-06-15
US20080139648A1 (en) 2008-06-12
CA2590277C (en) 2014-07-08
KR20070085523A (ko) 2007-08-27

Similar Documents

Publication Publication Date Title
NO20073353L (no) Produkt som har prostaglandin som har fluoratom i molekyl
WO2009115557A3 (en) Fungicide hydroximoyl-tetrazole derivatives
AR112074A2 (es) Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3
WO2009090237A3 (en) Fungicide hydroximoyl-tetrazole derivatives
WO2012016186A8 (en) Macrocyclic kinase inhibitors and uses thereof
NO20084403L (no) Cykloheksylpyrazol-lactamderivater som inhibitorer av II-beta-hydroksysteroid dehydrogenase I
WO2009089011A3 (en) Resveratrol formulations
EA201390198A1 (ru) Гетероциклическое соединение
WO2013037479A8 (en) Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
WO2013061004A8 (fr) Nouveaux composés di-substitués de la diamino-3,4-cyclobutène-3-dione-1,2 utiles dans le traitement de pathologies médiées par des chimiokines
WO2008094992A3 (en) 2-aminopyridine derivatives useful as kinase inhibitors
MY160703A (en) Crystalline forms of (r) -5- [3-chloro-4-(2,3-dihydroxy) - benz [z] ylidene] -2- ([z]-propylimino) -3-0-tolyl-thiazolidin-4-one
MA35750B1 (fr) Dérivés de nucléoside substitué 2',4'-difluoro-2'-méthyle en tant qu'inhibiteurs de la réplication de l'arn du vhc (virus de l'hépatite c)
EA201490803A1 (ru) Составы этанерцепта, стабилизированные ксилитом
WO2011056985A3 (en) Substituted heterocyclic compounds
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
WO2008027584A3 (en) 5- (2-furyl)-1, 3-thiazole derivatives useful as inhibitors of phosphatidylinositol 3-kinase
WO2011006935A3 (en) Tetrazole derivatives
NO20084363L (no) 2-Substituerte 4-benzylftalazinonderivater som histamin H1- og H3-antagonister
EA201170680A1 (ru) Ингибиторы акт и p70 s6-киназы
EA201791321A1 (ru) Составы ингибитора lfa-1
BRPI1011804A2 (pt) composição farmacêutica com solubilidade melhorada
PH12021553202A1 (en) Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamide
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
WO2010107482A3 (en) Germicidal composition

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees